Education
About Us
Working with TipRanks
Follow Us
Acusphere (ACUS)
:ACUS
ACUS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.25 - $0.25
Previous CloseN/A
Volume200.00
Average Volume (3M)0.00
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.00
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding4,951,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
ACUS FAQ
What was Acusphere’s price range in the past 12 months?
Acusphere lowest stock price was $0.25 and its highest was $0.25 in the past 12 months.
What is Acusphere’s market cap?
Currently, no data Available
When is Acusphere’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Acusphere’s earnings last quarter?
Currently, no data Available
Is Acusphere overvalued?
According to Wall Street analysts Acusphere’s price is currently Overvalued.
Does Acusphere pay dividends?
Acusphere does not currently pay dividends.
What is Acusphere’s EPS estimate?
Acusphere’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Acusphere have?
Acusphere has 4,951,000 shares outstanding.
What happened to Acusphere’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Acusphere?
Currently, no hedge funds are holding shares in ACUS
---
Company Description
Acusphere
Acusphere, Inc. operates as a specialty pharmaceutical company that develops and commercializes cardiovascular drugs. It offers Imagify (perflubutane polymer microspheres), a cardiovascular drug that evaluates myocardial perfusion and detects coronary artery disease. It provides Imagify as an injectable suspension. The company was formerly known as Polymers For Medicine, Inc. and changed its name to Acusphere, Inc. in March 2004. Acusphere, Inc. was founded in 1993 and is based in Watertown, Massachusetts.
---
Technical Analysis
Optinose
―
cbdMD
―
China SXT Pharmaceuticals
―
Petros Pharmaceuticals
―
Shuttle Pharmaceuticals Holdings, Inc.
―
---